These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

434 related items for PubMed ID: 18700638

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Optical platelet aggregation versus thromboxane metabolites in healthy individuals and patients with stable coronary artery disease after low-dose aspirin administration.
    Hedegaard SS, Hvas AM, Grove EL, Refsgaard J, Rocca B, Daví G, Kristensen SD.
    Thromb Res; 2009 May; 124(1):96-100. PubMed ID: 19215971
    [Abstract] [Full Text] [Related]

  • 3. Factors responsible for "aspirin resistance" - can we identify them?
    Postuła M, Tarchalska-Kryńska B, Filipiak KJ, Kosior D, Serafin A, Huczek Z, Opolski G.
    Kardiol Pol; 2010 Apr; 68(4):403-11; discussion 412-3. PubMed ID: 20425699
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Platelet response to low-dose enteric-coated aspirin in patients with stable cardiovascular disease.
    Maree AO, Curtin RJ, Dooley M, Conroy RM, Crean P, Cox D, Fitzgerald DJ.
    J Am Coll Cardiol; 2005 Oct 04; 46(7):1258-63. PubMed ID: 16198840
    [Abstract] [Full Text] [Related]

  • 7. Profile and prevalence of aspirin resistance in Indian patients with coronary artery disease.
    Sadiq PA, Puri A, Dixit M, Ghatak A, Dwivedi SK, Narain VS, Saran RK, Puri VK.
    Indian Heart J; 2005 Oct 04; 57(6):658-61. PubMed ID: 16521633
    [Abstract] [Full Text] [Related]

  • 8. [Aspirin resistance in patients taking small dose of aspirin].
    Wang CB, Hu DY, Shi XB, Zhu ZY, Zhu JY, Yang JG.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2006 Apr 04; 18(4):219-23. PubMed ID: 16647012
    [Abstract] [Full Text] [Related]

  • 9. Risk stratification after coronary artery bypass surgery by a point-of-care test of platelet function.
    Bevilacqua S, Alkodami AA, Volpi E, Cerillo AG, Berti S, Glauber M, Gianetti J.
    Ann Thorac Surg; 2009 Feb 04; 87(2):496-502. PubMed ID: 19161767
    [Abstract] [Full Text] [Related]

  • 10. Variability in platelet responsiveness to clopidogrel among 544 individuals.
    Serebruany VL, Steinhubl SR, Berger PB, Malinin AI, Bhatt DL, Topol EJ.
    J Am Coll Cardiol; 2005 Jan 18; 45(2):246-51. PubMed ID: 15653023
    [Abstract] [Full Text] [Related]

  • 11. Effect of aspirin dose, preparation, and withdrawal on platelet response in normal volunteers.
    Coleman JL, Alberts MJ.
    Am J Cardiol; 2006 Sep 15; 98(6):838-41. PubMed ID: 16950199
    [Abstract] [Full Text] [Related]

  • 12. Do proton pump inhibitors attenuate the effect of aspirin on platelet aggregation? A randomized crossover study.
    Adamopoulos AB, Sakizlis GN, Nasothimiou EG, Anastasopoulou I, Anastasakou E, Kotsi P, Karafoulidou A, Stergiou GS.
    J Cardiovasc Pharmacol; 2009 Aug 15; 54(2):163-8. PubMed ID: 19568178
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Aspirin-resistant platelet aggregation in a cohort of patients with coronary heart disease.
    Pamukcu B, Oflaz H, Onur I, Oncul A, Umman B, Koylan N, Bugra Z, Meric M, Nisanci Y.
    Blood Coagul Fibrinolysis; 2007 Jul 15; 18(5):461-5. PubMed ID: 17581321
    [Abstract] [Full Text] [Related]

  • 16. Pharmacodynamic effects of different aspirin dosing regimens in type 2 diabetes mellitus patients with coronary artery disease.
    Capodanno D, Patel A, Dharmashankar K, Ferreiro JL, Ueno M, Kodali M, Tomasello SD, Capranzano P, Seecheran N, Darlington A, Tello-Montoliu A, Desai B, Bass TA, Angiolillo DJ.
    Circ Cardiovasc Interv; 2011 Apr 01; 4(2):180-7. PubMed ID: 21386092
    [Abstract] [Full Text] [Related]

  • 17. Aspirin resistance in secondary stroke prevention.
    Berrouschot J, Schwetlick B, von Twickel G, Fischer C, Uhlemann H, Siegemund T, Siegemund A, Roessler A.
    Acta Neurol Scand; 2006 Jan 01; 113(1):31-5. PubMed ID: 16367896
    [Abstract] [Full Text] [Related]

  • 18. Platelet count, not oxidative stress, may contribute to inadequate platelet inhibition by aspirin.
    Lordkipanidzé M, Diodati JG, Turgeon J, Schampaert E, Palisaitis DA, Pharand C.
    Int J Cardiol; 2010 Aug 06; 143(1):43-50. PubMed ID: 19215991
    [Abstract] [Full Text] [Related]

  • 19. Low-dose aspirin increases aspirin resistance in patients with coronary artery disease.
    Lee PY, Chen WH, Ng W, Cheng X, Kwok JY, Tse HF, Lau CP.
    Am J Med; 2005 Jul 06; 118(7):723-7. PubMed ID: 15989905
    [Abstract] [Full Text] [Related]

  • 20. The Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack (PERFORM) study: baseline characteristics of the population.
    Bousser MG, Amarenco P, Chamorro A, Fisher M, Ford I, Fox K, Hennerici M, Mattle HP, Rothwell PM, PERFORM Study Investigators.
    Cerebrovasc Dis; 2009 Jul 06; 27(6):608-13. PubMed ID: 19407444
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.